Changes to Electronic Referrals at Sydney Local Health District
Sydney Local Health District (SLHD) is expanding its use of eReferrals for General Practice referrals and rolling out the NSW Health referral management platform, Engage Outpatients. The platform streamlines the triage and management of referrals, and provides secure, electronic communication with GP referrers and patients on the receipt and processing of referrals.
GPs will continue to refer to SLHD outpatient services via HealthLink SmartForms however more Royal Prince Alfred Hospital services are being added.
From Wednesday 11 June 2025, eReferral forms for most RPAH Services, alongside SLHD Women’s Health services, will be hosted in a new link on the HealthLink landing page:
Sydney LHD Women’s Health and RPA Hospital Services
The full list of services being added to this folder is:
| Bone Mineral Density Studies (Endocrinology and Rheumatology) | Cancer Genetics |
| Clinical Genetics | Dermatology |
| Diabetes | Endocrinology |
| Gynaecology (Pelvic Mesh) | Haematology (also for Canterbury Hospital) |
| Hand Therapy | High Risk Foot Service |
| Immunology and Allergy | Infectious Diseases |
| Lipid Clinic | Menopause |
| Metabolism and Obesity | Neurosurgery |
| Ophthalmology | Orthopaedics |
| Orthotics | Paediatric Medicine |
| Paediatric Surgery | Pain Management |
| Palliative Care | Physiotherapy |
| Renal | Respiratory Function testing |
| Respiratory Medicine | Rheumatology |
| Sleep medicine | Urology |
eReferral forms to all existing services across Concord Hospital, Canterbury Hospital, Balmain Hospital and SLHD Community services will remain under Sydney Local Health District Services.
Electronic referrals via HealthLink SmartForms are the preferred method of referral to the majority services across SLHD. GP referrals sent via other methods (fax, email, walk-in) will start to be phased out over the coming months.
For more information on how to submit and update eReferrals, please refer to the HealthLink Smartform user guides.
For service specific information, refer to HealthPathways Sydney.
If you require any support with eReferrals to SLHD, please contact the eReferral Project Team – SLHD-EReferralProject@health.nsw.gov.au or 0476 768 628.
Health Referral Forms
Eora Health Messenger Winter 2025 EORA Health Messenger Winter 2025 edition is live now. This quarterly edition covers the following topics: Celebrating connection Winter events to enjoy Community engagement opportunities Reflections on seasonal change Latest local news and updates
Immunisation Weekly Update: Cessation of MBS COVID-19 vaccine support items from 1 July 2025 2025 updates to anaphylaxis training RSV vaccine safety data and resources New NCIRS meningococcal vaccines FAQs resource Influenza vaccination coverage data update Changes to pharmacist vaccination programs Education Cessation of MBS COVID-19 vaccine support items from…
Immunisation Weekly Update: Stay up to date with measles Protecting your patients from the flu First clade 1b mpox case in Australia Remind your patients about RSV and maternal vaccinations in pregnancy New First Nations and childhood vaccination resources Stay up to date with measles Lunch and learn recording and…
Immunisation Weekly Update: Federal ministers and national media react to falling vaccination rates Be mindful of measles before and after Hajj COVID-19 vaccine update and new resource Flu Vaccine Updates ‘Possible but rare’ RSV vaccine risk First Nations maternal vaccinations poster Federal ministers and national media react to falling vaccination…
Immunisation Weekly Update: CESPHN seeking Immunisation Working Group clinical representatives Lunch and Learn: Measles awareness and prevention in 2025 Concerns rise as vaccination rates continue to fall The latest influenza vaccination coverage data Access to existing Q Fever statements in the Q Fever Register to end 30 June 2025 Have…
Immunisation Weekly Update: Lunch and Learn: Measles awareness and prevention in 2025 Australia on track for record number of flu cases Free SMS recall – 2025 Quality Improvement programs Large-scale revamp of Handbook immunocompromised chapter In case you missed it… Beyfortus™ (nirsevimab) eligibility expansion Access to the Australian Immunisation Register…
